• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Optimi Goes Down Under with New Australian Subsidiary

VANCOUVER / SYDNEY – Optimi Health Corp., a commercial-stage pharmaceutical developer and manufacturer of regulated psychedelic drug products, announced the establishment of Optimi Australia Pty Ltd, a wholly owned subsidiary responsible for distribution and business ...

Curaleaf Refuses to Back Down

STAMFORD – One day after the Alberta Securities Commission (ASC) dismissed Curaleaf's application to shut down Aurora Cannabis's at-the-market (ATM) share issuance program, Curaleaf Holdings pushed back with a firm statement, insisting the ruling changes ...

Greece Shuts the Door on Cannabis Flower in Retail

ATHENS – Greece's medicines regulator has ordered an immediate, nationwide halt to the retail sale of dried Cannabis flower, pulling a product that had built a foothold in c-stores, vending machines, and specialized shops across ...

Decibel Reports Q1 2026 Financial Results

CALGARY – Decibel Cannabis Company Inc. posted its financial results for the first quarter of 2026, showing notable gains in both domestic and international operations. The producer highlighted continued momentum from its branded products in ...

Bioxyne Double-Strikes in LATAM and Europe

SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...

Rubicon Organics Reports Q1 2026 Financial Results

VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...

Subscribe To Our Newsletter

Go to Top